Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection
- PMID: 38197653
- PMCID: PMC10872457
- DOI: 10.4049/jimmunol.2300509
Memory-like NK Cells Are a Critical Component of Vaccine-Induced Immunity to Trypanosoma cruzi Infection
Abstract
Chagas disease by Trypanosoma cruzi infection is a major public health issue. The available therapeutic agents have limited efficacy and significant side effects. A reliable vaccine would reduce the threat of T. cruzi infections and prevent Chagas disease. Understanding the immune response to this infection would improve vaccine design. We previously demonstrated that adoptively transferred NK cells from mice immunized with highly attenuated T. cruzi, GFP-DDDHA strain, provided potent protection in naive recipients against secondary lethal challenge with various wild-type (WT) strains. To understand the importance of NK cells in protecting mice against T. cruzi infection, we performed an in-depth characterization of NK cell phenotype, responses, and memory-like traits during acute infections due to GFP-DDDHA and WT strains and in immunized mice during a recall response to a WT lethal challenge. NK cells robustly expanded and became more mature and cytolytic during the GFP-DDDHA strain immunization. NK cells in immunized mice responded more robustly after WT lethal challenge than during an acute primary WT infection. In addition, protection by immunization with the GFP-DDDHA strain is significantly weakened in NK cell-deficient mice and did not prevent parasitemia from WT lethal challenge, indicating that NK cells with memory-like traits were a critical component for early control of WT lethal challenge. Prior T. cruzi vaccine development studies have not included studies of this rapid NK response. These findings provide insights into overcoming existing challenges in developing a safe and effective vaccine to prevent this infection.
Copyright © 2024 by The American Association of Immunologists, Inc.
Similar articles
-
Induction of Effective Immunity against Trypanosoma cruzi.Infect Immun. 2020 Mar 23;88(4):e00908-19. doi: 10.1128/IAI.00908-19. Print 2020 Mar 23. Infect Immun. 2020. PMID: 31907197 Free PMC article.
-
Inducible suicide vector systems for Trypanosoma cruzi.Microbes Infect. 2015 Jun;17(6):440-50. doi: 10.1016/j.micinf.2015.04.003. Epub 2015 Apr 18. Microbes Infect. 2015. PMID: 25899945
-
TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization.Front Immunol. 2019 Jun 26;10:1456. doi: 10.3389/fimmu.2019.01456. eCollection 2019. Front Immunol. 2019. PMID: 31293599 Free PMC article.
-
Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.Parasitol Int. 2008 Mar;57(1):38-48. doi: 10.1016/j.parint.2007.07.005. Epub 2007 Aug 1. Parasitol Int. 2008. PMID: 17728174 Review.
-
Immunity and vaccine development efforts against Trypanosoma cruzi.Acta Trop. 2019 Dec;200:105168. doi: 10.1016/j.actatropica.2019.105168. Epub 2019 Sep 9. Acta Trop. 2019. PMID: 31513763 Free PMC article. Review.
References
-
- Narni-Mancinelli E, Ugolini S, and Vivier E. 2013. Tuning the threshold of natural killer cell responses. Curr Opin Immunol 25: 53–58. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases